Sime to invest RM97.7mil in US biotech company Verdezyne


President Barack Obama, standing right, and Malaysian Prime Minister Najib, standing left, applaud as Bill Radany, president & CEO of Verdezyne, right, and Tan Sri Dato' Seri Mohd Bakke Salleh, President & Group Chief Executive of Sime Darby Berhad, left, participate in the signing of major commercial agreements with American businesses at the Ritz-Carlton in Kuala Lumpur,

PETALING JAYA: Sime Darby Bhd is acquiring a substantial stake in United States-based industrial biotechnology company Verdezyne Inc to pursue strategic growth areas for its plantation business.

Sime Darby president and group chief executive officer Tan Sri Mohd Bakke Salleh said in a statement that “Sime Darby is taking strategically measured steps to build and nurture a sustainable portfolio of palm-related industrial biotechnology companies.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , Sime Darby , Verdezyne , Barack Obama , Najib

   

Next In Business News

EG Industries expands partnership wtih US-based R&D firm
FBM KLCI rises despite broader market decline
Malaysia's exports rise in 1Q to RM362.41bil
Malaysia's economy likely grew 3.9% y-o-y in Q1 - advance estimate
Oil prices surge 3% on reports of Israeli strikes on Iran
US bonds rally on reports of Middle East missile strike
Fed policymakers agree: there's no urgency to cut rates
Ringgit opens easier against US$ as Fed turns hawkish
Main Market-bound Keyfield to gain from AWB market upcycle
FBM KLCI continues rebound after two days of recovery

Others Also Read